Skip to content
2000
  1. Home
  2. A-Z Publications
  3. The International Journal of Gastroenterology and Hepatology Diseases
  4. Volume 1, Issue 2
  5. Article
Volume 1, Issue 2
  • ISSN: 2666-2906
  • E-ISSN: 2666-2914
file format pdf download PDF
file format text download EPUB
side by side viewer icon HTML

Abstract

Data quality of idiosyncratic drug-induced liver injury (iDILI) cases is insufficient in the US LiverTox database due to the lack of a robust causality assessment method such as the Roussel Uclaf Causality Assessment Method (RUCAM), not allowing for appropriate use of included cases by physicians. Despite some shortcomings, case quality is much better in national DILI registries using the prospective RUCAM, with a few exemptions.

© 2022 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/ijghd/10.2174/2666290601666210325091553
2021-03-25
2025-01-19

  • From This Site

    /content/journals/ijghd/10.2174/2666290601666210325091553
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

/deliver/fulltext/ijghd/1/2/IJGHD-1-2-E010621192456.html?itemId=/content/journals/ijghd/10.2174/2666290601666210325091553&mimeType=html&fmt=ahah

References

  1. KeL. LuC. ShenR. LuT. MaB. HuaY. Knowledge mapping of drug-induced liver injury: a scientometric investigation (2010-2019).Front. Pharmacol.20201184210.3389/fphar.2020.00842 32581801
     [Google Scholar]
  2. AndradeR.J. LucenaM.I. FernándezM.C. Spanish Group for the Study of Drug-Induced Liver Disease. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period.Gastroenterology2005129251252110.1016/j.gastro.2005.05.006 16083708
     [Google Scholar]
  3. DananG. BénichouC. Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries.J. Clin. Epidemiol.199346111323133010.1016/0895‑4356(93)90101‑6 8229110
     [Google Scholar]
  4. BenichouC. DananG. FlahaultA. Causality assessment of adverse reactions to drugs--II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge.J. Clin. Epidemiol.199346111331133610.1016/0895‑4356(93)90102‑7 8229111
     [Google Scholar]
  5. DananG. TeschkeR. RUCAM in drug and herb induced liver injury: The update.In: Special Issue “Drug, Herb, and Dietary Supplement Hepatotoxicity”Int J Mol Sci20161711410.3390/ijms17010014
     [Google Scholar]
  6. TeschkeR. DananG. Worldwide use of RUCAM for causality assessment in 81,856 DILI and 14,029 HILI cases published 1993 - mid 2020: A comprehensive analysis.Medicines (Basel)20207106210.3390/medicines7100062 33003400
     [Google Scholar]
  7. AithalG.P. WatkinsP.B. AndradeR.J. Case definition and phenotype standardization in drug-induced liver injury.Clin. Pharmacol. Ther.201189680681510.1038/clpt.2011.58 21544079
     [Google Scholar]
  8. ShenT. LiuY. ShangJ. Incidence and etiology of drug-induced liver injury in Mainland China.Gastroenterology2019156822302241.e1110.1053/j.gastro.2019.02.002 30742832
     [Google Scholar]
  9. RosenbergJ.J. HigleyC. ShabaziS. LewisJ.H. Selected highlights and controversies of drug-induced liver injury from the recent literature.World J Gastroenterol Hepatol Endosc Res20201116
     [Google Scholar]
  10. Robles-DiazM. LucenaM.I. KaplowitzN. Spanish DILI Registry; SLatinDILI Network; Safer and Faster Evidence-based Translation Consortium. Use of Hy’s law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury.Gastroenterology20141471109118.e510.1053/j.gastro.2014.03.050 24704526
     [Google Scholar]
  11. Lo ReV.III FordeK.A. LewisJ.D. Reply.Clin. Gastroenterol. Hepatol.201614691891910.1016/j.cgh.2016.02.013 26883072
     [Google Scholar]
  12. RegevA. BjörnssonE.S. Drug-induced liver injury: morbidity, mortality, and Hy’s law.Gastroenterology20141471202410.1053/j.gastro.2014.05.027 24880009
     [Google Scholar]
  13. TillmannH.L. RockeyD.C. Improved prediction of the need for liver transplantation in patients with drug-induced liver injury?Gastroenterology20141476144110.1053/j.gastro.2014.07.059 25450085
     [Google Scholar]
  14. TanselA. KanwalF. HollingerF.B. Use of Hy’s Law, R criteria, and nR criteria to predict acute liver failure or transplantation in patients with drug-induced liver injury.Gastroenterology2015148245210.1053/j.gastro.2014.11.046 25532807
     [Google Scholar]
  15. TeschkeR. AndradeR.J. Drug-induced liver injury: expanding our knowledge by enlarging population analysis with prospective and scoring causality assessment.Gastroenterology201514871271127310.1053/j.gastro.2015.04.027 25921378
     [Google Scholar]
  16. BessoneF. HernandezN. DávalosM. Building a Spanish-Latin American network on drug induced liver injury: much to get from a joint collaborative initiative.Ann. Hepatol.201211454454910.1016/S1665‑2681(19)31469‑3 22710943
     [Google Scholar]
  17. BessoneF. HernandezN. LucenaM.I. AndradeR.J. Latin Dili Network Latindilin And Spanish Dili Registry. The Latin American DILI Registry experience: A successful ongoing collaborative strategic initiative.Int. J. Mol. Sci.201617331310.3390/ijms17030313 26938524
     [Google Scholar]
  18. BessoneF. Robles-DiazM. HernandezN. Medina-CalizI. LucenaM.I. AndradeR.J. Assessment of serious acute and chronic idiosyncratic drug-induced liver injury in clinical practice.Semin. Liver Dis.201939338139410.1055/s‑0039‑1685519 31049898
     [Google Scholar]
  19. TeschkeR. AndradeR.J. Drug, Herb, and Dietary Supplement Hepatotoxicity.Int. J. Mol. Sci.20161791488http://www.mdpi.com/journal/ijms/special_issues/Hepatotoxicity10.3390/ijms1709148827608014
     [Google Scholar]
  20. TeschkeR. SchmidtM. Controversy on a newly published case of assumed acute liver failure one day after kava use: issues of confounders, causality, and an undetermined cause.J Mod Med Chem20208334010.12970/2308‑8044.2020.08.04
     [Google Scholar]
  21. BjörnssonE.S. Hepatotoxicity by drugs: the most common implicated agents. In: Special Issue “Drug, Herb, and Dietary Supplement Hepatotoxicity.Int. J. Mol. Sci.20161722410.3390/ijms17020224
     [Google Scholar]
  22. BjörnssonE.S. HoofnagleJ.H. Categorization of drugs implicated in causing liver injury: Critical assessment based on published case reports.Hepatology201663259060310.1002/hep.28323 26517184
     [Google Scholar]
  23. TeschkeR. Top-ranking drugs out of 3312 drug-induced liver injury cases evaluated by the Roussel Uclaf Causality Assessment Method.Expert Opin. Drug Metab. Toxicol.201814111169118710.1080/17425255.2018.1539077 30354694
     [Google Scholar]
  24. TeschkeR. SchulzeJ. EickhoffA. DananG. Drug induced liver injury: Can biomarkers assist RUCAM in causality assessment? Special issue: Molecular Research on Drug Induced Liver Injury.Int. J. Mol. Sci.20171880310.3390/ijms180408038
     [Google Scholar]
  25. TeschkeR. EickhoffA. BrownA.C. NeumanM.G. SchulzeJ. Diagnostic biomarkers in liver injury by drugs, herbs, and alcohol: Tricky dilemma after EMA correctly and officially retracted Letter of Support.Int. J. Mol. Sci.201921121210.3390/ijms21010212 31892250
     [Google Scholar]
  26. TeschkeR. Idiosyncratic DILI: Analysis of 46,266 cases assessed for causality by RUCAM and published from 2014 to early 2019. In: Special issue: Clinical drug induced liver injury: Current diagnostic and mechanistic challenges.Front Pharmacol201910.389/fphar.2019.00730
     [Google Scholar]
  27. BjörnssonE. OlssonR. Outcome and prognostic markers in severe drug-induced liver disease.Hepatology200542248148910.1002/hep.20800 16025496
     [Google Scholar]
  28. BjörnssonE.S. BergmannO.M. BjörnssonH.K. KvaranR.B. OlafssonS. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland.Gastroenterology201314471419142510.1053/j.gastro.2013.02.006 23419359
     [Google Scholar]
  29. HoofnagleJ.H. NavarroV.J. Drug-induced liver injury: Icelandic lessons.Gastroenterology201314471335133610.1053/j.gastro.2013.04.026 23623967
     [Google Scholar]
  30. BjörnssonE. JacobsenE.I. KalaitzakisE. Hepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketing.J. Hepatol.201256237438010.1016/j.jhep.2011.07.023 21889469
     [Google Scholar]
  31. BaderT. Yes! Statins can be given to liver patients.J. Hepatol.201256230530710.1016/j.jhep.2011.08.016 21963520
     [Google Scholar]
/content/journals/ijghd/10.2174/2666290601666210325091553
Loading
DILI Cases in Registries and Databases: An Analysis of Quality
Int J Gastroenterol Hepatol Dis 1, e010621192456 (2022); https://doi.org/10.2174/2666290601666210325091553
/content/journals/ijghd/10.2174/2666290601666210325091553
/content/journals/ijghd/10.2174/2666290601666210325091553
Loading

Data & Media loading...


  • Article Type:     Editorial
Keyword(s): CAMs; causality assessment methods; DILI; DILI registries; drug-induced liver injury; herb induced liver injury; HILI; LiverTox; Roussel Uclaf Causality Assessment Method; RUCAM

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test